What is the current price of Venus Remedies' stock?

Venus Remedies' stock is currently priced at ₹727.05 on the NSE as of the latest trading day, reflecting a rise of 5.19% from the previous close of ₹691.15.

How has Venus Remedies' stock performed over the past year?

Over the past year, the stock has increased by 72.23%, driven by strong demand within the pharmaceutical sector and company performance milestones. It recently reached a 52-week high of ₹758.00.

What are the key financial metrics for Venus Remedies?

Venus Remedies has a P/E ratio of 13.82, an EPS of ₹52.60, and an interest coverage ratio of 793.6, demonstrating strong financial health and profitability.

What do the technical indicators suggest about Venus Remedies' stock?

The RSI of 75.56 suggest an overbought condition, while a strong MACD and ADX signal sustained bullish momentum, indicating a robust upward trend. However, investors should watch for potential volatility.

How does Venus Remedies compare to the pharmaceutical sector?

Venus Remedies exhibits a strong performance within the Indian healthcare sector, capitalizing on increased demand for generic and specialty pharmaceuticals. Its financial and market metrics remain competitive within the industry.

IN Stocks

VENUSREM.NS Stock Update: Analyzing the Robust Growth of Venus Remedies Limited

ByHuzaifa Zahoor December 2, 2025

Venus Remedies Limited (VENUSREM.NS) has made headlines with its impressive rally, climbing 5.19% on the NSE India to close at ₹727.05. With a market cap of ₹9.72 billion, Venus Remedies has captured attention with its robust growth, making it one of the top gainers. Let’s delve into the details driving this upward trajectory.